A new laboratory assistant can learn to spot a “≥99%” claim within seconds, but that is not the same as understanding a batch. In a research-use-only environment, the more useful skill is asking which analytical tests sit behind the headline, which sample they refer to and whether contaminant screening has been documented. Training should begin with the certificate of analysis (CoA), not the marketing line. All materials discussed here are for controlled laboratory and analytical research only and are not for human or veterinary use.
Research Sciences supplies research peptides, laboratory accessories and preparation tools for in-vitro work in the UK. Some pages may still show Imperial Sciences UK or Imperial Peptides UK wording; the FAQs describe Research Sciences as the parent company of Imperial Peptides UK, with Imperial Peptides UK continuing as a brand. The assistant should read documentation against the current shop name and the specific batch record, not assume a familiar label tells the whole story.
Why a purity headline cannot carry the whole training load
Purity is important, but it is not a complete release criterion. A CoA may report purity by HPLC, identity information and other analytical checks, yet the assistant still needs to know which tests were performed, what sample was tested and whether the document belongs to the batch in hand. The Research Sciences homepage currently displays published wording such as “≥99% Verified Purity” and lists “CoAs Janoshik Analytical Reports”; those statements should be reconfirmed on the live site and against the CoA supplied with the specific batch. A headline figure is a prompt for verification, not a substitute for it.
Contaminant screening is where training becomes practical. Site-published guidance describes an expanded testing framework that includes heavy metals and endotoxin screening alongside CoA documentation, and educational posts discuss heavy-metal (ICP-MS) and endotoxin evaluation. The assistant does not need to invent limits or interpret a certificate beyond their competence. If a supplier advertises only a headline purity number, the assistant should ask for the supporting tests: which analytical methods were used, which batch is covered, whether contaminant screening is reported and where the current CoA can be opened.
The FAQs state that every product includes a CoA for HPLC purity and identity, and that products are subject to final verification and quality checks in the UK before release. That is a useful training anchor, but it is still batch-specific. The assistant should compare the product name, catalogue reference and batch information on the vial label with the CoA. Vial labels use a reference format combining SKU code and expiry date, for example BPC10-03/27, and that reference should be quoted when contacting the shop about documentation. Cap colour is not an indicator of identity, analytical quality or manufacturing origin, so it must never be used as a short-cut in a materials check.
Storage and dispatch context also belongs in the training. Research Sciences describes temperature-aware storage and tracked UK dispatch, but delivery timing should be reconfirmed against current published terms. More importantly for the assistant, a clean chain of documentation supports a clean chain of custody. All materials remain research-use-only and not for human or veterinary use, consumption, administration or clinical application.
Building a contaminant-screening checklist for the new assistant
The first checklist item is not “Does the page say high purity?” It is “Which tests are reported for this exact batch, and can the assistant locate them?” A practical review should open the CoA and look for the product identity, batch or internal test reference, test methods, reported results and any contaminant screening. The assistant should be able to explain the difference between a purity result, an identity result and a contaminant-screening result, even if a specialist interprets the data. The Research Sciences FAQs describe CoAs as being linked to supported products; the assistant’s job is to follow that link and read the batch document, not to rely on a category-page slogan.
The second checklist item is traceability. Restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. The assistant should record the batch reference, date of receipt, CoA reference and storage location. If a CoA mentions Janoshik Analytical Reports, the assistant should check the actual document that accompanies the batch. Materials managers can review current catalogue options through the all-products listing and Buy peptides pages, then verify each item against its own product page and batch CoA.
A third checklist item is formulation awareness. The FAQs state that all peptides contain trace amounts of mannitol, an excipient used to support lyophilisation and storage; the assistant should recognise it in documentation rather than mistaking every listed ingredient for a contaminant. The shop also states that it does not supply blended peptides and recommends buying peptides individually, combining only within a controlled experimental design. A simple, traceable single-vial record is easier to reconcile than an undocumented blend. Catalogue examples such as Tesamorelin 5mg, Bacteriostatic Water 10ml or 10ml Mixing Water, MT-1 10mg, Storage Container, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg and BPC-157 10mg should each be treated as a separate research-use-only item with its own documentation.
From document review to in-vitro bench discipline
Training should connect contaminant screening to handling. The assistant should allow vials to reach room temperature before opening, work in a clean environment, remove only the amount required for the experiment and store lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light. Repeated freeze–thaw cycles should be avoided. Reconstituted peptides are less stable and should be stored at 2–8°C for short-term laboratory use. These are in-vitro workflow controls, not clinical instructions, and every material remains not for human or veterinary use.
If an in-vitro assay requires reconstitution, the assistant should calculate diluent volume and target concentration for that laboratory experiment, label the vial with solvent, concentration and date, and record the calculation. The Research Sciences reconstitution calculator is described for laboratory research use only; it must not be used for human or veterinary dosing. The assistant should also check whether the product page or CoA states specific storage or handling information for that item. For MT-1 10mg, the product page describes a lyophilised research peptide and storage at −20°C protected from moisture and light, with 2–8°C after reconstitution; those details belong to that listing and should not be copied onto other products.
The final sign-off for a new assistant should therefore be procedural: can they locate the correct batch CoA, identify the tests reported, ask for missing contaminant-screening information, record the internal test reference and follow the in-vitro storage and handling instructions? That is a more defensible training standard than memorising a purity headline. It also keeps the laboratory’s documentation aligned with the shop’s research-use-only position, under which lawful use, safe handling, storage, disposal and suitability for the intended research application remain the purchaser’s responsibility.
A Sofia-born astrophysicist residing in Buenos Aires, Valentina blogs under the motto “Science is salsa—mix it well.” Expect lucid breakdowns of quantum entanglement, reviews of indie RPGs, and tango etiquette guides. She juggles fire at weekend festivals (safely), proving gravity is optional for good storytelling.
